STOCK TITAN

Flora Growth Corp Stock Price, News & Analysis

FLGC Nasdaq

Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.

Flora Growth Corp (FLGC) operates at the intersection of cannabis cultivation and pharmaceutical distribution, maintaining a vertically integrated model across 15+ countries. This page delivers essential updates about corporate milestones, regulatory compliance, and market expansion efforts.

Investors and industry observers will find comprehensive coverage of earnings reports, strategic partnerships, product launches, and operational developments. Our aggregation ensures you stay informed about FLGC’s commercial wholesale activities, consumer brand portfolio, and pharmaceutical-grade medical solutions.

Key updates include international supply chain advancements, CBD product innovations, and compliance achievements in regulated markets. Bookmark this page for real-time access to Flora Growth’s press releases and third-party analysis, curated to support informed decision-making.

Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) received a 180-day extension from Nasdaq to meet the $1.00 minimum bid price requirement for continued listing. This extension runs until July 3, 2023. The company's compliance is contingent on maintaining market value for publicly held shares and possibly executing a reverse stock split. If compliance is not achieved by the deadline, shares may face delisting. Currently, the notification does not affect the trading of FLGC shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.31%
Tags
none
-
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) has reported exporting nearly 1,000 kilograms of cannabis dry flower and derivatives to Europe and the U.S. in Q4 2022. The company received an updated cannabis export and production quota from the Colombian government, which includes four new proprietary genetics and greater domestic production for medical markets. These exports are a part of the full commercialization of its Bucaramanga facilities. The acquisition of Franchise Global Health allows Flora direct distribution access to Germany and the potential for future growth in the recreational market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
none
-
Rhea-AI Summary

Flora Growth (NASDAQ:FLGC) has successfully completed its acquisition of Franchise Global Health (TSXV:FGH) as of December 23, 2022. This transformative deal enhances Flora's presence in Germany's medical cannabis market, enabling sales across over 1,200 pharmacies and potential cannabis distribution throughout 28 countries. For the nine-month period ending September 30, 2022, Flora reported revenues of $25.7 million and gross profits of $11.5 million, while FGH reported C$42 million in revenues. The acquisition is poised to expand Flora's distribution network, creating new opportunities in the EU market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.47%
Tags
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) announced a registered direct offering of 12.5 million common shares and warrants to purchase an equal number of shares. The offering price is $0.40 per share and warrant, raising approximately $5.0 million in gross proceeds. The funds will be allocated for capital expenditures, increasing operating capacity, working capital, and general corporate purposes. The offering is expected to close around December 13, 2022, subject to customary conditions. Alliance Global Partners is the sole placement agent for the offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.8%
Tags
-
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) reported substantial revenue growth for Q3 2022, with revenue reaching $10.8 million, a 414% increase year-over-year. For the nine-month period, revenue totaled $25.7 million, up 510%. Gross profit also saw impressive growth, rising 703% to $5.0 million, improving gross margins to 46.2%. The company reaffirmed its revenue guidance for 2022, expecting $35 million - $45 million. Flora has signed an agreement to acquire Franchise Global Health, enhancing its international presence in the cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
-
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) has announced the completion of Flora Lab 4, a new laboratory in Bogota, Colombia. This facility will focus on manufacturing prescription-grade cannabis formulations. The lab aims to provide high-quality medicinal cannabis to patients and doctors in Colombia. Initial formulations target conditions such as social anxiety and acne. The lab is awaiting INVIMA regulatory inspection for certification. Flora Growth is dedicated to advancing medicinal cannabis through research and development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.38%
Tags
none
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) announced that over 73% of Franchise Global Health Inc. (TSXV: FGH) shareholders support Flora's acquisition of FGH, set for a vote on December 13, 2022. This acquisition is viewed as highly beneficial, potentially enhancing Flora's presence in Germany and the broader EU cannabis market. The transaction involves Flora issuing approximately 36.5 million to 43.5 million shares to FGH shareholders, who will face a 90-day selling restriction. Positive shareholder feedback has been noted, reinforcing confidence in this strategic move.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.6%
Tags
-
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) will host an analyst call on October 26, 2022, at 2:00 p.m. EST. The call will discuss the recent acquisition of Franchise Global Health and strategic growth opportunities in the cannabis market. Analysts can pre-register by contacting ir@floragrowth.com. The webcast will be available at this link and archived on their website approximately 24 hours post-event. The call is part of Flora's commitment to transparency and engagement with its stakeholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.13%
Tags
conferences
-
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) has signed an agreement to acquire Franchise Global Health Inc. (TSXV: FGH), expanding its footprint in the European medical cannabis market. The acquisition will allow Flora to distribute Colombian cannabis directly to German pharmacies, encompassing 1,200 pharmacies and 28 additional countries. With FGH's reported revenue of CA$30.1 million and gross profit of CA$2.1 million in the first half of 2022, Flora anticipates annual synergies of at least US$3 million post-acquisition. Regulatory approvals from the Supreme Court of British Columbia and FGH shareholders are required for completion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
Rhea-AI Summary

Flora Growth Corp. (NASDAQ: FLGC) announced the successful export of its high-CBD dried cannabis flower to Switzerland and the Czech Republic, along with its first shipment of CBD isolate to the United States. CEO Luis Merchan highlighted this milestone as a testament to the growing demand for its Colombian products. The global CBD market is projected to surge to US$47 billion by 2028. The company also launched a commercial website for buyers to access its cannabis offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.66%
Tags
none

FAQ

What is the current stock price of Flora Growth (FLGC)?

The current stock price of Flora Growth (FLGC) is $0.604 as of May 7, 2025.

What is the market cap of Flora Growth (FLGC)?

The market cap of Flora Growth (FLGC) is approximately 11.7M.
Flora Growth Corp

Nasdaq:FLGC

FLGC Rankings

FLGC Stock Data

11.66M
16.53M
35.25%
8.36%
3.18%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
FORT LAUDERDALE